We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Getting To A Rule For Reverse Payments

Law360, New York (June 28, 2012, 1:24 PM EDT) -- For a decade now, courts have been grappling with whether so-called “reverse payments” by pioneer pharmaceutical manufacturers to generic competitors in settlement of patent infringement litigation violate the antitrust laws, and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.